Combination treatment of the liver cancer cell lines HepG2 and SMMC7721 with IFN-λ3 and Sora promoted the loss of MMP and induced reactive oxygen species production more effectively than the monotreatment with either component [43]. This evidence concerns the gene IFNL3 and liver cancer.